158 related articles for article (PubMed ID: 31803765)
21. Immunohistochemical characterization of subependymal giant cell astrocytomas.
Lopes MB; Altermatt HJ; Scheithauer BW; Shepherd CW; VandenBerg SR
Acta Neuropathol; 1996; 91(4):368-75. PubMed ID: 8928613
[TBL] [Abstract][Full Text] [Related]
22. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
[TBL] [Abstract][Full Text] [Related]
23. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
[TBL] [Abstract][Full Text] [Related]
24. Inter-pathologist agreement on diagnosis, classification and grading of canine glioma.
Krane GA; Shockley KR; Malarkey DE; Miller AD; Miller CR; Tokarz DA; Jensen HL; Janardhan KS; Breen M; Mariani CL
Vet Comp Oncol; 2022 Dec; 20(4):881-889. PubMed ID: 35856268
[TBL] [Abstract][Full Text] [Related]
25. Low grade diffuse gliomas: shared cellular composition and morphometric differences.
Kinjo S; Hirato J; Nakazato Y
Neuropathology; 2008 Oct; 28(5):455-65. PubMed ID: 18282166
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
[TBL] [Abstract][Full Text] [Related]
27. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
28. Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines.
Tlhyama T; Lee VM; Trojanowski JQ
Am J Pathol; 1993 Mar; 142(3):883-92. PubMed ID: 8456947
[TBL] [Abstract][Full Text] [Related]
29. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.
Colin C; Virard I; Baeza N; Tchoghandjian A; Fernandez C; Bouvier C; Calisti A; Tong S; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):431-9. PubMed ID: 17442061
[TBL] [Abstract][Full Text] [Related]
30. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
31. Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma.
Wang Y; Hagel C; Hamel W; Müller S; Kluwe L; Westphal M
Acta Neuropathol; 1998 Oct; 96(4):357-64. PubMed ID: 9797000
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and ultrastructural characterization of brain tumors in S100beta-v-erbB transgenic rats.
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Neuropathology; 2008 Dec; 28(6):591-8. PubMed ID: 18498286
[TBL] [Abstract][Full Text] [Related]
33. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
[TBL] [Abstract][Full Text] [Related]
34. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
35. Effects of autolysis and prolonged formalin fixation on histomorphology and immunohistochemistry of normal canine brain tissue: an experimental study.
Koehler JW; Miller AD; Rissi DR
J Vet Diagn Invest; 2024 Mar; 36(2):169-176. PubMed ID: 38212877
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin immunoreactivity in gliomas.
Ng HK; Lo ST
Histopathology; 1989 Apr; 14(4):359-68. PubMed ID: 2472343
[TBL] [Abstract][Full Text] [Related]
37. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
38. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
39. The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma.
Wang J; Liu Z; Du J; Cui Y; Fang J; Xu L; Li G
Neuropathology; 2016 Oct; 36(5):432-440. PubMed ID: 26919073
[TBL] [Abstract][Full Text] [Related]
40. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]